Neuroscience, Spasticity

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Adult Spasticity- Carenity 2 survey

User Validation

In order to access this resource you must validate that you're an HCP
  • Please enter your full name and BIG-number to validate your HCP status.
  • Please enter your email to receive news and updates from Ipsen. This is optional but you can unsubscribe at any time using the link at the bottom of all of our marketing emails.

Please download the full PDF presentation using the link below

Click to rate this post!
[Total: 0 Average: 0]

DYS-NL-000797 15/09/2022

Ipsen Farmaceutica B.V. Taurusavenue 33b 2132 LS Hoofddorp Nederland